当前位置:
X-MOL 学术
›
Expert Opin. Drug Deliv.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus
Expert Opinion on Drug Delivery ( IF 6.6 ) Pub Date : 2024-03-20 , DOI: 10.1080/17425247.2024.2331216 Devika Unnithan 1 , Ali Sartaj 1 , Mohammad Kashif Iqubal 2 , Javed Ali 1 , Sanjula Baboota 1
Expert Opinion on Drug Delivery ( IF 6.6 ) Pub Date : 2024-03-20 , DOI: 10.1080/17425247.2024.2331216 Devika Unnithan 1 , Ali Sartaj 1 , Mohammad Kashif Iqubal 2 , Javed Ali 1 , Sanjula Baboota 1
Affiliation
The current treatment modalities available for Parkinson’s disease (PD) prove inadequate due to the inherent constraints in effectively transporting bioactive compounds across the blood-brain barri...
中文翻译:
关于帕金森病联合治疗进展的近代注释:基于纳米载体的联合方法和未来预期。第二部分:纳米载体设计和开发重点
由于有效地将生物活性化合物穿过血脑屏障的固有限制,目前可用于帕金森病(PD)的治疗方式被证明是不够的。
更新日期:2024-03-23
中文翻译:
关于帕金森病联合治疗进展的近代注释:基于纳米载体的联合方法和未来预期。第二部分:纳米载体设计和开发重点
由于有效地将生物活性化合物穿过血脑屏障的固有限制,目前可用于帕金森病(PD)的治疗方式被证明是不够的。